Skip to content
Genialis co-authored an article on endogenous function of thiopurine S-methyltransferase (TPMT). Read more →
Get in touch with us today!
|
info@genialis.com
Search for:
RNA Biomarkers
Technology
ResponderID
Genialis Expressions
Interactive Demo
Use Cases
Value We Deliver
About Us
Meet Our Team
Careers
Compliance
Media
News and Events
Scientific Publications
Press Releases
Talking Precision Medicine Podcast
Get in Touch
Search for:
RNA Biomarkers
Technology
ResponderID
Genialis Expressions
Interactive Demo
Use Cases
Value We Deliver
About Us
Meet Our Team
Careers
Compliance
Media
News and Events
Scientific Publications
Press Releases
Talking Precision Medicine Podcast
Get in Touch
RNA Biomarkers
Technology
ResponderID
Genialis Expressions
Interactive Demo
Use Cases
Value We Deliver
About Us
Meet Our Team
Careers
Compliance
Media
News and Events
Scientific Publications
Press Releases
Talking Precision Medicine Podcast
Get in Touch
Search for:
Scientific Publications
Explore our scientific publications and posters on RNA biomarker discovery. Learn how we use machine learning and big data analytics to advance precision medicine.
February 19, 2024
Transcriptome analysis reveals involvement of thiopurine S-methyltransferase in oxidation-reduction processes
December 13, 2023
Normalizing RNA-seq data in Python with RNAnorm
December 7, 2023
Genialis Expands into Triple-Negative Breast Cancer Research: Insights from SABCS 2023
November 3, 2023
Genialis Presents Data at SITC 2023 on RNA-Based Biomarkers to Predict Immunotherapy Response
August 3, 2023
Genialis and BioLab Win Best Regular Paper at the 21st International Conference of Artificial Intelligence in Medicine
June 13, 2023
Genialis Presents Poster on KRAS Expression Signature Validation in Lung Cancer
May 23, 2023
Genialis and OncXerna publish a novel RNA-seq and machine learning based biomarker in Frontiers in Oncology
April 17, 2023
The Xerna™ TME Panel potentially predicts response to a combination of the TLR9 agonist vidutolimod and PD-1 inhibitor pembrolizumab in metastatic melanomas with prior anti-PD-1 treatment
April 5, 2023
ResponderID™: The Biology-First Machine Learning Platform for Biomarker Discovery
1
2
Next
Page load link